NCT05285358
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +18 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Gallbladder Carcinoma
Explore clinical trials studying Gallbladder Carcinoma. Study availability and eligibility vary by location and protocol.
16 public trials
5 recruiting studies
Gallbladder Carcinoma trial results
NCT07641036
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +14 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
NCT07146646
- Conditions
- Adenocarcinoma, Biliary Tract Cancer, Biliary Tract Diseases, +13 more
- Locations
-
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT06715839
- Conditions
- Appendiceal Neoplasms, Appendix Cancer, Bile Duct Carcinoma, +46 more
- Locations
-
- Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai Municipality, China
Recruiting
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
NCT04183712
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +6 more
- Locations
-
- Renji hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Not yet recruiting
Outcomes After Liver and Biliary Resection at a High-Volume Center
NCT07556835
- Conditions
- Adenocarcinoma, Benign Liver Disease, Biliary Tract Diseases, +22 more
- Locations
-
- San Jacopo Hospital Pistoia, Tuscany, Italy
Active, not recruiting
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
NCT02151084
- Conditions
- Biliary Tract Carcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Active, not recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, not recruiting
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
NCT04430738
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- Mayo Clinic Scottsdale, Arizona, United States
- University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
Active, not recruiting
Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma"
NCT05222854
- Conditions
- Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +6 more
- Locations
-
- Frankfurter Institut für Klinische Krebsforschung IKF GmbH Frankfurt am Main, Germany